Mr. Mike Withrow reports

BC BUD DEPOT ANNOUNCES STARTING DEVELOPMENT ON THEIR GENETICS VAULT TO UNLEASH NEW PROPRIETARY STRAINS FOR AREV BRANDS INTERNATIONAL LTD

BC Bud Depot has commenced an intensive phase of developing new proprietary strains for Arev Brands International Ltd. Seeing a deficiency in the variety and qualities of cannabis strains made available to the medicinal and recreational markets by licensed producers in Canada, BC Bud Depot has begun germination and selection from its extensive proprietary genetics vault of breeding stock for new strain development. The BC Bud Depot genetics vault is a collection of over 200 unique elite cannabis strains collected over 20 years. Many of the strains are believed to no longer exist anywhere else in the world.

BC Bud Depot has also recently developed a high cannabidiol hemp strain that will be submitted to the CFIA for a new classification of hemp to be registered under the recent Cannabis Act.

As reported on Sept. 7, 2018, Arev Brands International completed the acquisition of 100 per cent of all assets under the BC Bud Depot brand, including all existing and future cannabis strains bred by the company. The company intends to license these proprietary cannabis genetics within the Canadian industry and internationally, and will directly supply genetic material to licensed producers either owned by or partnered with Arev. This positions the company to realize multiple revenue streams, while substantially improving the genetic quality and diversity of the current medicinal and recreational landscapes.

Matthew Harvey, lead breeder for BC Bud Depot, states: "Our mandate is to improve the quality of cannabis available to both medicinal and recreational consumers in Canada and abroad. We have the privilege of drawing upon a vault of seeds containing popular strains long thought to be lost to the world. This will ensure an improvement and expansion of the available cannabis gene pool."

Mr. Withrow, chief executive officer for Arev Brands International, states: "Access to our extensive rare seeds and our knowledge in breeding and developing strains to produce high yields in short cycles matched to advanced extraction systems parlayed into our formulation expertise will stand up against any of the multibillion-dollar giants in the space. Not only are we efficient in our development we are efficient in our spending. There's much more to come."

The company has issued 50,000 common shares at a deemed price of 27.5 cents as signing bonuses to a consultant of the company.

About Arev Brands International Ltd.

Arev Brands International produces and delivers functional compounds and ingredients from its world-class extraction systems. Arev is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. Arev innovates through extraction to produce extracts from specific selected plant and exude from trees that address five areas of health, including anxiety, pain management, insomnia, central nervous system disorders and libido.

We seek Safe Harbor.